United Kingdom · Question · Written question
UIN 160629
Advanced Therapy Medicinal Products
Original
Introduced
1 March 2021
Last action
9 March 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
9 March 2021
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of new innovative payment models that would be required to support patient access to innovative and potentially curative gene and cell therapy.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
1 March 2021
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of new innovative payment models that would be required to support patient access to innovative and potentially curative gene and cell therapy.
Source: Commons
9 March 2021
Answer
NHS England and NHS Improvement published the ‘NHS commercial framework for new medicines’ on 23 February 2021. The framework sets out the routes to commissioning for medicines and states that the main route for commissioning medicines, which includes gen...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-03-01/160629
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1293489
- uk · wq-1293489 · source updated 9 March 2021